Citigroup’s Moleculin Biotech MBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.7K | Buy |
85,283
+82,495
| +2,959% | +$24.9K | ﹤0.01% | 4288 |
|
|
2025
Q1 | $2.71K | Buy |
+2,788
| New | +$2.71K | ﹤0.01% | 4548 |
|
|
2017
Q1 | – | Sell |
-83
| Closed | -$17K | – | 4869 |
|
|
2016
Q4 | $17K | Buy |
83
+27
| +48% | +$5.53K | ﹤0.01% | 4429 |
|
|
2016
Q3 | $29K | Hold |
56
| – | – | ﹤0.01% | 4002 |
|
|
2016
Q2 | $33K | Buy |
+56
| New | +$33K | ﹤0.01% | 3915 |
|